Lack of evidence for direct phosphorylation of recombinantly expressed P2X2 and P2X3 receptors by protein kinase C

被引:17
作者
Franklin, Cindy [1 ]
Braam, Ursula [1 ]
Eisele, Thomas [1 ]
Schmalzing, Gunther [1 ]
Hausmann, Ralf [1 ]
机构
[1] Rhein Westfal TH Aachen, Univ Hosp, Dept Mol Pharmacol, D-52074 Aachen, Germany
关键词
phosphorylation; protein kinase C; P2X receptors; P2X(2); P2X(3);
D O I
10.1007/s11302-007-9067-x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
P2X(3) and P2X(2+3) receptors are present on sensory neurons, where they contribute not only to transient nociceptive responses, but also to hypersensitivity underlying pathological pain states elicited by nerve injuries. Increased signalling through P2X(3) and P2X(2+3) receptors may arise from an increased routing to the plasma membrane and/or gain of function of pre-existing receptors. An obvious effector mechanism for functional modulation is protein kinase C (PKC)-mediated phosphorylation, since all P2X family members share a conserved consensus sequence for PKC, TXR/K, within the intracellularly located N-terminal domain. Contradictory reports have been published regarding the exact role of this motif. In the present study, we confirm that site-directed elimination of the potential phosphor-acceptor threonine or the basic residue in the P+2 position of the TXR/K sequence accelerates desensitization of P2X(2) receptors and abolishes P2X(3) receptor function. Moreover, the PKC activator phorbol 12-myristate 13-acetate increased P2X(3) (but not P2X(2)) receptor-mediated currents. Biochemically, however, we were unable to demonstrate by various experimental approaches a direct phosphorylation of wildtype P2X(2) and P2X(3) receptors expressed in both Xenopus laevis oocytes and HEK293 cells. In conclusion, our data support the view that the TXR/K motif plays an important role in P2X function and that phorbol 12-myristate 13-acetate is capable of modulating some P2X receptor subtypes. The underlying mechanism, however, is unlikely to involve direct PKC-mediated P2X receptor phosphorylation.
引用
收藏
页码:377 / 388
页数:12
相关论文
共 42 条
  • [1] MEMBRANE CAPACITY MEASUREMENTS ON FROG SKELETAL-MUSCLE IN MEDIA OF LOW ION CONTENT
    ADRIAN, RH
    ALMERS, W
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 1974, 237 (03): : 573 - 605
  • [2] Trimeric architecture of homomeric P2X2 and heteromeric P2X1+2 receptor subtypes
    Aschrafi, A
    Sadtler, S
    Niculescu, C
    Rettinger, J
    Schmalzing, G
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2004, 342 (01) : 333 - 343
  • [3] Atomic force microscopy imaging demonstrates that P2X2 receptors are trimers but that P2X6 receptor subunits do not oligomerize
    Barrera, NP
    Ormond, SJ
    Henderson, RM
    Murrell-Lagnado, RD
    Edwardson, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (11) : 10759 - 10765
  • [4] A synthetic peptide derived from the non-structural protein 3 of hepatitis C virus serves as a specific substrate for PKC
    Borowski, P
    Resch, K
    Schmitz, H
    Heiland, M
    [J]. BIOLOGICAL CHEMISTRY, 2000, 381 (01) : 19 - 27
  • [5] A protein kinase C site highly conserved in P2X subunits controls the desensitization kinetics of P2X2 ATP-gated channels
    Boué-Grabot, É
    Archambault, V
    Séguéla, P
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (14) : 10190 - 10195
  • [6] Protein kinase C regulation of P2X3 receptors is unlikely to involve direct receptor phosphorylation
    Brown, David A.
    Yule, David I.
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2007, 1773 (02): : 166 - 175
  • [7] Introduction: P2 receptors
    Burnstock, G
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (08) : 793 - 803
  • [8] Purinergic P2 receptors as targets for novel analgesics
    Burnstock, Geoffrey
    [J]. PHARMACOLOGY & THERAPEUTICS, 2006, 110 (03) : 433 - 454
  • [9] Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state
    Chen, Y
    Li, GW
    Wang, C
    Gu, YP
    Huang, LYM
    [J]. PAIN, 2005, 119 (1-3) : 38 - 48
  • [10] Chizh BA, 2001, PHARMACOL REV, V53, P553